FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4293105087> ?p ?o ?g. }

• W4293105087 endingPage "1010" @default.
• W4293105087 startingPage "1001" @default.
• W4293105087 abstract "Abstract There is a need for biomarkers to predict and measure the severity of immune effector cell–associated neurotoxicity syndrome (ICANS). Glial fibrillary acidic protein (GFAP) and neurofilament light chain (NfL) are well-validated biomarkers of astroglial and neuronal injury, respectively. We hypothesized that pretreatment GFAP and NfL levels can predict the risk of subsequent ICANS and that increases in GFAP and NfL levels during treatment reflect ICANS severity. We measured cerebrospinal fluid GFAP (cGFAP) and NfL (cNfL) along with serum NfL (sNfL) levels at pretreatment and day 7 to 10 after chimeric antigen receptor (CAR) T-cell infusion in 3 pediatric cohorts treated with CD19- or CD19/CD22-directed CAR T cells. cGFAP and cNfL levels increased during grade ≥1 ICANS in patients treated with CD19-directed CAR T cells but not in those who received CD19/CD22-directed CAR T cells. The sNfL levels did not increase during ICANS. Prelymphodepletion cGFAP, cNfL, and sNfL levels were not predictive of subsequent ICANS. Elevated baseline cGFAP levels were associated with a history of transplantation. Patients with prior central nervous system (CNS) radiation had higher cNfL levels, and elevated baseline sNfL levels were associated with a history of peripheral neuropathy. Thus, cGFAP and cNfL may be useful biomarkers for measuring the severity of CNS injury during ICANS in children. Elevated baseline levels of cGFAP, cNfL, and sNfL likely reflect the cumulative injury to the central and peripheral nervous systems from prior treatment. However, levels of any of the 3 biomarkers before CAR T-cell infusion did not predict the risk of ICANS." @default.
• W4293105087 created "2022-08-26" @default.
• W4293105087 creator A5008468212 @default.
• W4293105087 creator A5017501517 @default.
• W4293105087 creator A5023585989 @default.
• W4293105087 creator A5025161374 @default.
• W4293105087 creator A5027819567 @default.
• W4293105087 creator A5045336612 @default.
• W4293105087 creator A5065740168 @default.
• W4293105087 creator A5082052104 @default.
• W4293105087 creator A5084868086 @default.
• W4293105087 creator A5091226342 @default.
• W4293105087 date "2023-03-20" @default.
• W4293105087 modified "2023-09-30" @default.
• W4293105087 title "GFAP and NfL increase during neurotoxicity from high baseline levels in pediatric CD19-CAR T-cell patients" @default.
• W4293105087 cites W2015541518 @default.
• W4293105087 cites W2128275881 @default.
• W4293105087 cites W2184491519 @default.
• W4293105087 cites W2342233016 @default.
• W4293105087 cites W2516761392 @default.
• W4293105087 cites W2606654718 @default.
• W4293105087 cites W2763751953 @default.
• W4293105087 cites W2788285407 @default.
• W4293105087 cites W2791660181 @default.
• W4293105087 cites W2805523469 @default.
• W4293105087 cites W2805778897 @default.
• W4293105087 cites W2884386651 @default.
• W4293105087 cites W2889223700 @default.
• W4293105087 cites W2899385155 @default.
• W4293105087 cites W2901478468 @default.
• W4293105087 cites W2905654445 @default.
• W4293105087 cites W2910539598 @default.
• W4293105087 cites W2944288721 @default.
• W4293105087 cites W2994618797 @default.
• W4293105087 cites W3007888754 @default.
• W4293105087 cites W3025037284 @default.
• W4293105087 cites W3025155289 @default.
• W4293105087 cites W3030734898 @default.
• W4293105087 cites W3035931772 @default.
• W4293105087 cites W3041099631 @default.
• W4293105087 cites W3048184133 @default.
• W4293105087 cites W3074382982 @default.
• W4293105087 cites W3081041696 @default.
• W4293105087 cites W3097006554 @default.
• W4293105087 cites W3097365520 @default.
• W4293105087 cites W3103742316 @default.
• W4293105087 cites W3110691903 @default.
• W4293105087 cites W3167068736 @default.
• W4293105087 cites W3170817209 @default.
• W4293105087 cites W3189962845 @default.
• W4293105087 cites W3198859173 @default.
• W4293105087 cites W3213141384 @default.
• W4293105087 cites W4205496583 @default.
• W4293105087 cites W4206801414 @default.
• W4293105087 cites W4210837060 @default.
• W4293105087 cites W4212846153 @default.
• W4293105087 cites W4213416459 @default.
• W4293105087 cites W4280556006 @default.
• W4293105087 doi "https://doi.org/10.1182/bloodadvances.2022008119" @default.
• W4293105087 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36006611" @default.
• W4293105087 hasPublicationYear "2023" @default.
• W4293105087 type Work @default.
• W4293105087 citedByCount "3" @default.
• W4293105087 countsByYear W42931050872023 @default.
• W4293105087 crossrefType "journal-article" @default.
• W4293105087 hasAuthorship W4293105087A5008468212 @default.
• W4293105087 hasAuthorship W4293105087A5017501517 @default.
• W4293105087 hasAuthorship W4293105087A5023585989 @default.
• W4293105087 hasAuthorship W4293105087A5025161374 @default.
• W4293105087 hasAuthorship W4293105087A5027819567 @default.
• W4293105087 hasAuthorship W4293105087A5045336612 @default.
• W4293105087 hasAuthorship W4293105087A5065740168 @default.
• W4293105087 hasAuthorship W4293105087A5082052104 @default.
• W4293105087 hasAuthorship W4293105087A5084868086 @default.
• W4293105087 hasAuthorship W4293105087A5091226342 @default.
• W4293105087 hasBestOaLocation W42931050871 @default.
• W4293105087 hasConcept C126322002 @default.
• W4293105087 hasConcept C2778957590 @default.
• W4293105087 hasConcept C2779491297 @default.
• W4293105087 hasConcept C2781197716 @default.
• W4293105087 hasConcept C29730261 @default.
• W4293105087 hasConcept C3017910909 @default.
• W4293105087 hasConcept C529278444 @default.
• W4293105087 hasConcept C55493867 @default.
• W4293105087 hasConcept C71924100 @default.
• W4293105087 hasConcept C86803240 @default.
• W4293105087 hasConceptScore W4293105087C126322002 @default.
• W4293105087 hasConceptScore W4293105087C2778957590 @default.
• W4293105087 hasConceptScore W4293105087C2779491297 @default.
• W4293105087 hasConceptScore W4293105087C2781197716 @default.
• W4293105087 hasConceptScore W4293105087C29730261 @default.
• W4293105087 hasConceptScore W4293105087C3017910909 @default.
• W4293105087 hasConceptScore W4293105087C529278444 @default.
• W4293105087 hasConceptScore W4293105087C55493867 @default.
• W4293105087 hasConceptScore W4293105087C71924100 @default.
• W4293105087 hasConceptScore W4293105087C86803240 @default.
• W4293105087 hasIssue "6" @default.
• W4293105087 hasLocation W42931050871 @default.

• next